Bernard-Gauthier V., Boudjemeline M., Rosa-Neto P., Thiel A., Schirrmacher R. (2013). Towards tropomyosin-related kinase B (TrkB) receptor ligands for brain imaging with PET: radiosynthesis and evaluation, Bioorg Med Chem, 21(24), 7816-7829. Find out more.

Burhan A. M., Bartha R., Bocti C., Borrie M., Laforce R., Rosa-Neto P., Soucy J. P. (2013). Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012, Alzheimers Res Ther, 5(Suppl 1), S4. Find out more.

Gauthier S., Leuzy A., Racine E., Rosa-Neto P. (2013). Diagnosis and management of Alzheimer's disease: Past, present and future ethical issues, Prog Neurobiol. Find out more.

Gauthier S., Rosa-Neto P. (2013). Dementia: Disclosure of results to participants in dementia research, Nat Rev Neurol. Find out more.

Kandratavicius L., Rosa-Neto P., Monteiro M. R., Guiot M. C., Assirati J. A., Carlotti C. G., Kobayashi E., Leite J. P. (2013). Distinct increased metabotropic glutamate receptor type 5 (mGluR5) in temporal lobe epilepsy with and without hippocampal sclerosis, Hippocampus, 23(12), 1212-30. Find out more.

Leuzy A., Rosa-Neto P., Gauthier S. (2013). Revising the diagnostic criteria for Alzheimer’s disease: the use of biomarkers and attendant ethical implications, Int J Sci Society, 4.

Masellis M., Sherborn K., Rosa-Neto P., Sadovnick D. A., Hsiung G. Y., Black S. E., Prasad S., Williams M., Gauthier S. (2013). Early-onset dementias: diagnostic and etiological considerations, Alzheimers Res Ther, 5(Suppl 1), S7. Find out more.

Papadopoulos P., Rosa-Neto P., Rochford J., Hamel E. (2013). Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-beta and cerebrovascular pathology, PLoS One, 8(7), e68612. Find out more.

Parent M. J., Bedard M. A., Aliaga A., Minuzzi L., Mechawar N., Soucy J. P., Schirrmacher E., Kostikov A., Gauthier S., Rosa-Neto P. (2013). Cholinergic Depletion in Alzheimer's Disease Shown by [(18) F]FEOBV Autoradiography, Int J Mol Imaging, 2013, 205045. Find out more.

Parent M. J., Cyr M., Aliaga A., Kostikov A., Schirrmacher E., Soucy J. P., Mechawar N., Rosa-Neto P., Bedard M. A. (2013). Concordance between in vivo and postmortem measurements of cholinergic denervation in rats using PET with [18F]FEOBV and choline acetyltransferase immunochemistry, EJNMMI Res, 3(1), 70. Find out more.

Rosa-Neto P., Hsiung G. Y., Masellis M. (2013). Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians, Alzheimers Res Ther, 5(Suppl 1), S8. Find out more.

Rowley J., Fonov V., Wu O., Eskildsen S. F., Schoemaker D., Wu L., Mohades S., Shin M., Sziklas V., Cheewakriengkrai L., Shmuel A., Dagher A., Gauthier S., Rosa-Neto P., Alzheimer's Disease Neuroimaging Initiative (2013). White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease, PLoS One, 8(9), e74776. Find out more.

Schilling L. P., Kieling R. R., Pascoal T. A., Kim H. I., Lee M. C., Kim Y. H., Paglioli E., Rosa-Neto P., Costa J. C., Palmini A. (2013). Bilateral perisylvian ulegyria: an under-recognized, surgically remediable epileptic syndrome, Epilepsia, 54(8), 1360-7. Find out more.

Soucy J. P., Bartha R., Bocti C., Borrie M., Burhan A. M., Laforce R., Rosa-Neto P. (2013). Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012, Alzheimers Res Ther, 5(Suppl 1), S3. Find out more.

Zhao L., Boucher M., Rosa-Neto P., Evans A. C. (2013). Impact of scale space search on age- and gender-related changes in MRI-based cortical morphometry, Hum Brain Mapp, 34(9), 2113-28. Find out more.